---
title: "Mahamaya Lifesciences Ltd (544611) — Share Price, Financials & Analysis"
symbol: "544611"
company: "Mahamaya Lifesciences Ltd"
canonical: "https://tapetide.com/stocks/544611"
isin: "INE0U9D01019"
nse_symbol: "MAHAMAYALIFESCIENCESLTD"
bse_code: "544611"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 432.98
generated_at: "2026-09-13T19:40:02.874Z"
---

# Mahamaya Lifesciences Ltd (544611)

Canonical page: https://tapetide.com/stocks/544611

## Company

- **NSE Symbol:** MAHAMAYALIFESCIENCESLTD
- **BSE Code:** 544611
- **ISIN:** INE0U9D01019
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2025-11-18
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** mahamayalifesciences.com/home

## About

ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:45.402320Z.

- **Market Cap:** ₹432.98 Cr
- **Classification:** SME
- **P/E (reported):** 25.9
- **Book Value:** ₹52.09
- **Price to Book:** 3.51
- **Dividend Yield:** 0%
- **ROE:** 26.19%
- **ROCE:** 42.64%
- **Debt to Equity:** 0.75
- **Revenue (yearly):** ₹328.87 Cr
- **Net Income:** ₹17.02 Cr
- **EBITDA:** ₹33.1 Cr
- **52-Week High:** ₹205.05
- **52-Week Low:** ₹111
- **RSI (14):** 50.95

## Key Insights

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 102.3% | -53.57% | -31.58% |
| ebitda margin growth | 9.9% | 3.29% | 12.68% | 43.43% |
| net income growth | 5.4% | 31.94% | 64% | 530.37% |
| revenue growth | 118.4% | 23.08% | 34% | 29.53% |
| roce | — | 11.19% | 62.13% | 32.03% |
| roe | — | 23.77% | 22.21% | 35.77% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 146 | 163 | 166 |
| Expenses | 133 | 148 | 149 |
| Operating Profit | 13 | 15 | 17 |
| OPM % | 9 | 9 | 10 |
| Other Income | 1 | 1 | 1 |
| Interest | 4 | 4 | 4 |
| Depreciation | 1 | 1 | 1 |
| Profit before tax | 10 | 11 | 12 |
| Tax % | 27 | 27 | 35 |
| Net Profit | 7 | 8 | 8 |
| EPS in Rs | 4.08 | 4.71 | 3.48 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 90 | 137 | 161 | 264 | 329 |
| Expenses | 84 | 128 | 148 | 241 | 296 |
| Operating Profit | 6 | 9 | 13 | 23 | 34 |
| OPM % | 7 | 6 | 8 | 9 | 10 |
| Other Income | 0 | 0 | 1 | 3 | 1 |
| Interest | 2 | 3 | 6 | 7 | 8 |
| Depreciation | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 4 | 5 | 7 | 17 | 24 |
| Tax % | 27 | 26 | 27 | 25 | 31 |
| Net Profit | 3 | 4 | 5 | 13 | 17 |
| EPS in Rs | 21.78 | 30.03 | 41.8 | 7.28 | 7.06 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 1 | 1 | 18 | 23 |
| Reserves | 14 | 18 | 23 | 32 | 99 |
| Borrowings | 19 | 24 | 55 | 58 | 91 |
| Other Liabilities | 21 | 34 | 33 | 81 | 98 |
| Total Liabilities | 56 | 78 | 112 | 188 | 310 |
| Fixed Assets | 20 | 21 | 21 | 27 | 38 |
| CWIP | 2 | 2 | 3 | 4 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 34 | 54 | 88 | 157 | 267 |
| Total Assets | 56 | 78 | 112 | 188 | 310 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2 | 1 | -23 | 1 | -30 |
| Cash from Investing Activity | -3 | -3 | -2 | -8 | -16 |
| Cash from Financing Activity | 1 | 2 | 24 | 9 | 81 |
| Net Cash Flow | 0 | 1 | 0 | 1 | 35 |
| Free Cash Flow | -1 | -2 | -25 | -8 | -46 |
| CFO/OP | 56 | 24 | -162 | 12 | -75 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 37 | 25 | 64 | 67 | 78 |
| Inventory Days | 93 | 109 | 137 | 167 | — |
| Days Payable | 83 | 87 | 61 | 92 | — |
| Cash Conversion Cycle | 47 | 48 | 140 | 142 | 78 |
| Working Capital Days | 8 | 9 | 14 | 29 | 49 |
| ROCE % | — | 20 | 21 | 26 | 20 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2026 |
| --- | --- |
| Promoters | 56.35% |
| FIIs | 4.77% |
| DIIs | 2.52% |
| Government | 0% |
| Public | 10.65% |
| Others | 25.71% |
| No. of Shareholders | 584 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 4 / 7

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 180.45 | Sell |
| EMA (10) | 181.85 | Sell |
| SMA (20) | 186.24 | Sell |
| EMA (20) | 182.47 | Sell |
| SMA (50) | 177.54 | Buy |
| EMA (50) | 179.54 | Sell |
| SMA (100) | 176.65 | Buy |
| EMA (100) | 175.96 | Buy |
| SMA (200) | 169.94 | Buy |
| EMA (200) | 169.94 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.9 | Neutral |
| MACD (12,26,9) | 0.14 | Sell |
| Stochastic (14,3,3) | 24.37 | Neutral |
| ADX (14) | 19.06 | Neutral |
| Williams %R (14) | -90.52 | Buy |
| ATR (14) | 8.21 | High Volatility |
| ROC (12) | -9.08 | Sell |
| Stoch RSI (14) | 10.56 | Buy |
| UO (7,14,28) | 25.41 | Buy |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7dc1ba03-2dc1-4584-9a9d-0fd3bfd86643.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8605abd4-d7c7-4ee8-b843-61c6c0ebe95a.pdf) |
| 2026-09-07 | [Notice Of 24Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2f33efd-e9ee-4b38-a946-653e8f3992f7.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=504e8168-d56b-48c0-8663-2ca2f425de73.pdf) |
| 2026-08-25 | [Appointment of Company Secretary and Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd09fa91-38c0-4ba8-ad90-e1b37eda8634.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f63d1e04-a67f-442a-85fc-115e90d459b0.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e7ded6c-f105-47c5-a182-5afff2acb0e3.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce744d0d-1062-4fe6-87c3-530ac499b9b5.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bf9634b-fb8e-4bec-905c-59a8f5432314.pdf) |
| 2026-07-10 | [Non-Applicability Of The Compliance On Corporate Governance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77cdf449-ad22-45e0-a37b-68ce6eb4f5b9.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07790eb8-8fd8-4006-bef9-ababc770a625.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-25 | [The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports Thereon](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e92fb1e-ed49-4b33-b6aa-5d4fe45ec094.pdf) |
| 2025-12-02 | [Submission Of Half Yearly Financial Results - September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cb34c8c-baf4-4848-9800-a770f590a70e.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Company withdrew from Arihant Capital Bharat Connect virtual conference scheduled March 9, 2026 due to scheduling constraints. | [Announcement Under Regulation 30 (LODR)-Intimation Of Withdrawn Of Participation In Virtual Conference On Monday 9" March 2026. 9 Mar - Company withdrew from Arihant Capital Bharat Connect virtual conference scheduled March 9, 2026 due to scheduling constraints.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ecf8a88d-d9e6-4263-8772-3ab748030d5c.pdf) |
| 5 May - Company says Annual Secretarial Compliance Report for FY2026 is not applicable under Regulation 24A. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 5 May - Company says Annual Secretarial Compliance Report for FY2026 is not applicable under Regulation 24A.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/11bebf2d-6fdc-4ae5-b8b6-69b3d1362a19.pdf) |
| 5 Mar - Management to attend Arihant Capital Bharat Connect virtual conference on 9 March 2026, 5–6 PM. | [Intimation Of Participation In Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 On Monday 9Th March 2026. 5 Mar - Management to attend Arihant Capital Bharat Connect virtual conference on 9 March 2026, 5–6 PM.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/67feb8db-a3aa-4024-a4a2-7903d0d5c370.pdf) |
| 4 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; all shares remain in demat form. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 4 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; all shares remain in demat form.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18c13531-e1ee-4d17-b195-a586e9c038cf.pdf) |
| 30 Mar - Trading window closed from April 1, 2026 until 48 hours after FY2026 audited results. | [Closure of Trading Window 30 Mar - Trading window closed from April 1, 2026 until 48 hours after FY2026 audited results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c554ac4-7867-487b-b045-2561682e4b28.pdf) |
| 3 Apr - Promoter group disclosed no share encumbrance during FY ended 31 March 2026. | [Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011 3 Apr - Promoter group disclosed no share encumbrance during FY ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f8caa053-d722-49ea-bc3f-d7f3b91bf8c9.pdf) |
| 28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027. | [Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work 28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b8bc8b9-7b98-479b-b1d1-0300fd696ed6.pdf) |
| 28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027. | [Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work 28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0b8bc8b9-7b98-479b-b1d1-0300fd696ed6.pdf) |
| 17 Feb - Appointed Amarendra Mohapatra as VP-Finance & Accounts effective 17 Feb 2026; CA, 17+ years' experience. | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Appointment Of Senior Management Personnel (SMP) 17 Feb - Appointed Amarendra Mohapatra as VP-Finance & Accounts effective 17 Feb 2026; CA, 17+ years' experience.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ea898fd-67f8-45f6-9eea-2ac11bdd4461.pdf) |
| 17 Feb - Appointed Amarendra Mohapatra as VP Finance & Accounts (SMP) effective 17-Feb-2026; CA, 17+ years. | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Appointment Of Senior Management Personnel (SMP) 17 Feb - Appointed Amarendra Mohapatra as VP Finance & Accounts (SMP) effective 17-Feb-2026; CA, 17+ years.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3980248a-1b84-485c-8d07-32270c10a7b2.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_2561_SHARONBIO_2011_2012_21102013140012.zip) |
| from bse | [Financial Year 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080316.pdf) |
| from bse | [Financial Year 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080615.pdf) |
| from bse | [Financial Year 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080614.pdf) |
| from bse | [Financial Year 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080613.pdf) |
| from bse | [Financial Year 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080612.pdf) |
| from bse | [Financial Year 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080610.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:40:02.874Z.